Alkermes shares take another hit as the FDA shakes its head — again — on a weak case for '5461

Alkermes shares take another hit as the FDA shakes its head — again — on a weak case for '5461

Submitted by admin on February 1, 2019 - 10:41pm
Source: 
Endpoints
News Tags: 
Alkermes
FDA
ALKS-5461
Headline: 
Alkermes shares take another hit as the FDA shakes its head — again — on a weak case for '5461
snippet: 

The FDA really, really doesn’t like Alkermes’ NDA for its highly touted depression drug ALKS-5461.

Do Not Allow Advertisers to Use My Personal information